Erste Asset Management Gmb H Roivant Sciences Ltd. Transaction History
Erste Asset Management Gmb H
- $8.15 Trillion
- Q4 2024
A detailed history of Erste Asset Management Gmb H transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 214,000 shares of ROIV stock, worth $2.22 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
214,000
Previous 214,000
-0.0%
Holding current value
$2.22 Million
Previous $2.46 Billion
2.79%
% of portfolio
0.03%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$683 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$644 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$496 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$458 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$367 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.31B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...